{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:51:38Z","timestamp":1782939098259,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jjcc.2022.09.015","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T11:57:35Z","timestamp":1664971055000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study"],"prefix":"10.1016","volume":"81","author":[{"given":"Naoki","family":"Terasaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysis","family":"Spanopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Miyagoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2022.09.015_bb0005","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0010","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0015","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1253\/circj.CJ-20-0524","article-title":"Hypertrophic cardiomyopathy: a heterogeneous and lifelong disease in real world","volume":"84","author":"Kitaoka","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0020","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1253\/circj.CJ-20-0910","article-title":"JCS\/JHFS 2018 Guideline on the diagnosis and treatment of cardiomyopathies","volume":"85","author":"Kitaoka","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003\u20132011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0035","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population","volume":"3","author":"Siontis","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0050","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1002\/ehf2.13563","article-title":"Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"8","author":"Kubo","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0060","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heart.87.2.126","article-title":"Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey","volume":"87","author":"Miura","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9149(87)80107-8","article-title":"Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening","volume":"59","author":"Hada","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0075","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","article-title":"Validity of diagnoses, procedures, and laboratory data in Japanese administrative data","volume":"27","author":"Yamana","year":"2017","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chest.2018.11.009","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation with hypertrophic cardiomyopathy: a nationwide cohort study","volume":"155","author":"Jung","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0085","author":"Statistics Bureau of Japan"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1253\/circj.66.323","article-title":"Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys","volume":"66","author":"Matsumori","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0095","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, expenditures, and complications of multiple chronic conditions in the elderly","volume":"162","author":"Wolff","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2881","article-title":"Risk factors associated with ischemic stroke in Japanese patients with nonvalvular atrial fibrillation","volume":"3","author":"Okumura","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0110","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0735-1097(10)80014-2","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study","volume":"15","author":"Robinson","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0115","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ahj.2005.01.005","article-title":"The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey","volume":"150","author":"Cecchi","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40119-022-00257-7","article-title":"Treatment changes, healthcare resource utilization, and costs among patients with symptomatic obstructive hypertrophic cardiomyopathy: a claims database study","volume":"11","author":"Owens","year":"2022","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0125","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","article-title":"Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population","volume":"26","author":"Cecchi","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0735-1097(02)03004-8","article-title":"Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration","volume":"41","author":"Kofflard","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0145","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.amjcard.2003.07.027","article-title":"Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States","volume":"92","author":"Kitaoka","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ehf2.12178","article-title":"Contrast-enhanced computed tomography with myocardial three-dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy","volume":"4","author":"Hamatani","year":"2017","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0155","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1253\/circj.CJ-15-1100","article-title":"Extent of late gadolinium enhancement on cardiac magnetic resonance imaging in Japanese hypertrophic cardiomyopathy patients","volume":"80","author":"Hen","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2010.07.004","article-title":"Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study","volume":"56","author":"Kubo","year":"2010","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.09.015_bb0170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1253\/jcj.63.859","article-title":"Gender differences in the presentation of adult obstructive hypertrophic cardiomyopathy with resting gradient: a study of 122 patients","volume":"63","author":"Lin","year":"1999","journal-title":"Jpn Circ J"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508722002477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508722002477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:08:00Z","timestamp":1760274480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508722002477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0914508722002477"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2022.09.015","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2022.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}